- Cohesive OVD
- Dispersive OVD
Ophthalmology Viscosurgical Devices Market size was valued at USD 360 million in the year 2022 and is anticipated to reach 458.02 million by 2029 growing at a CAGR of 3.5% from 2023-2029. Cataracts are treated with ophthalmology viscosurgical devices (OVDs) with minimal disturbance to the eye structure. These are solutions or agents which contain chemicals like methylcellulose, hydroxypropyl, sodium hyaluronate, and chondroitin sulfate. Ophthalmic Visco Surgical Devices are also called as viscoelastic agents and a vital tool for the anterior segment surgeon. To create and maintain space in the anterior chamber of the eye during phacoemulsification and insertion of intraocular lens these ophthalmology viscosurgical devices are used. These are the transparent and gel substances with elastic and viscous properties. Ophthalmology Viscosurgical Devices market report gives a comprehensive outlook on the global market scenario, growth trends, and shares, with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The report gives historical, current, and future market sizes (USD Mn) on the basis of product type, application, end-user, and region. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, Key stakeholders of the report include manufacturers, distributors, policy makers, and service providers engaged in Ophthalmology Viscosurgical Devices.
Fastest Growing Market
Rise in cataract procedures is the major factor which is bolstering ophthalmic viscosurgical devices market growth. Rapid rise in the geriatric population which results in the rise of incidences and prevalence of various ocular disorders such as high myopia, diabetic retinopathy and cataract. Rise in awareness campaigns by NGOs about the seriousness of ocular disorders is expected to be one of the factor in boosting the growth of the ophthalmology viscosurgical devices market. However, shortage in skilled ophthalmologists, limited availability of the screening equipment in undeveloped countries are some of the factors that may hinder the global ophthalmic visco surgical devices market growth.
The ophthalmology visco surgical devices market size was valued at USD 360 million in 2022
The ophthalmology visco surgical devices market key players are: Carl Zeiss Meditec AG (Germany) and Abbott Laboratories (U.S.) Novartis AG (Switzerland) Valeant (Canada) Hyaltech Ltd. (U.K.) CIMA Technology Inc. (U.S.) Rayner (U.K.)
The ophthalmology visco surgical devices market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.